Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Cancer Research

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-08-0035PMID 18644979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway

  2008cited by this paper
• Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

  2007influential reference
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+α2β1+ Cell Population Is Enriched in Tumor-Initiating Cells

  2007cited by this paper
• Cyclopamine‐Mediated Hedgehog Pathway Inhibition Depletes Stem‐Like Cancer Cells in Glioblastoma

  2007cited by this paper
• Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential

  2007cited by this paper
• Erratum: Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+α2β1+ cell population is enriched in tumor-initiating cells (Cancer Research (2007) 67, (6796-6805))

  2007cited by this paper
• Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry‐based assay

  2007cited by this paper
• CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

  2007cited by this paper
• Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.

  2007cited by this paper
• Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with colorectal cancer

  2007cited by this paper
• Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.

  2006cited by this paper
• Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.

  2006cited by this paper
• Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

  2006cited by this paper
• Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties

  2006cited by this paper
• Cancer stem cell characteristics in retinoblastoma.

  2005cited by this paper
• Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples

  2005cited by this paper
• Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis.

  2004influential reference
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Aldehyde dehydrogenase gene superfamily: the 2002 update.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Aldehyde Dehydrogenase Gene Superfamily

  1999cited by this paper
• Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents.

  1997cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper
• Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

  1982cited by this paper

• BET inhibition enhances temozolomide sensitivity in cervical cancer cells through ALDH suppression and epigenetic reprogramming

  2026cites this paper
• Impact of ALDH1A1 Expression in Intrahepatic Cholangiocellular Carcinoma

  2025cites this paper
• Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers

  2025cites this paper
• State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment

  2025cites this paper
• Role of CD133 antibody-conjugated nanocarrier in enhancing the targetability of hepatocellular carcinoma stem cells

  2025cites this paper
• Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review)

  2025cites this paper
• Farnesoid X Receptor Attenuates the Tumorigenicity of Liver Cancer Stem Cells by Inhibiting STAT3 Phosphorylation

  2025influential citation
• Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance.

  2025cites this paper
• AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models.

  2025cites this paper
• Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments

  2025cites this paper
• Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors

  2025cites this paper
• Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)

  2024cites this paper
• Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells

  2024cites this paper
• FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness

  2024cites this paper
• Serum-volatile organic compounds in the diagnostics of esophageal cancer

  2024cites this paper
• Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation.

  2024cites this paper
• Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes.

  2024cites this paper
• Isolating Cancer Stem Cells from Solid Tumors.

  2024cites this paper
• SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma

  2024cites this paper
• ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation.

  2024cites this paper
• Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma

  2024cites this paper
• Isolation and identification of patient-derived liver cancer stem cells and development of personalized treatment strategies

  2024cites this paper
• Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy

  2024cites this paper
• Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review

  2024cites this paper
• Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma

  2023cites this paper
• High-Resolution In Situ High-Content Imaging of 3D-Bioprinted Single Breast Cancer Spheroids for Advanced Quantification of Benzo(a)pyrene Carcinogen-Induced Breast Cancer Stem Cells.

  2023cites this paper
• Stem cell therapy for hepatocellular carcinoma and end-stage liver disease

  2023cites this paper
• Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance

  2023cites this paper
• Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer

  2023cites this paper
• A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.

  2023cites this paper
• Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer

  2023cites this paper
• Aldehyde Dehydrogenase, a Marker of Normal and Malignant Stem Cells, Typifies Mesenchymal Progenitors in Perivascular Niches

  2023cites this paper
• The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression

  2023cites this paper
• Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance

  2023cites this paper
• ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers

  2023cites this paper
• Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency

  2023cites this paper
• The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond

  2023cites this paper
• Mechanisms of resistance to tyrosine kinase inhibitors in liver cancer stem cells and potential therapeutic approaches.

  2022cites this paper
• Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram

  2022cites this paper
• Perindopril sensitizes hepatocellular carcinoma to chemotherapy: A possible role of leptin / Wnt/ β-catenin axis with subsequent inhibition of liver cancer stem cells

  2022cites this paper
• Drug-tolerant persister cells in cancer therapy resistance.

  2022cites this paper
• CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4‐Fatty Acid β‐Oxidation Pathway

  2022cites this paper
• Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

  2022cites this paper
• Concise review: Cancer cell reprogramming and therapeutic implications

  2022cites this paper
• An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer.

  2022cites this paper
• Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

  2022cites this paper
• TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype

  2022cites this paper
• Isolation of cancer stem cells from cultured breast cancer cells and xenografted breast tumors based on aldehyde dehydrogenase activity.

  2022cites this paper
• An anti-alcoholism drug, disulfiram and copper complex improves radio-resistance of tumor-initiating cells in esophageal squamous cell carcinoma

  2022cites this paper
• The STAT family: key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment.

  2022cites this paper
• Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers

  2021cites this paper
• Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan

  2021cites this paper
• Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications

  2021cites this paper
• Aldehyde dehydrogenase expression may be a prognostic biomarker and associated with liver cirrhosis in patients resected for hepatocellular carcinoma.

  2021cites this paper
• The role of CD133 in hepatocellular carcinoma

  2021cites this paper
• Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics

  2021cites this paper
• The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells

  2021cites this paper
• HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

  2021cites this paper
• Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma

  2021cites this paper
• The interaction of disulfiram and H2S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth.

  2021cites this paper
• Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

  2021cites this paper
• Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer

  2021influential citation
• Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma.

  2021cites this paper
• Advances in Liver Cancer Stem Cell Isolation and their Characterization

  2021cites this paper
• A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro

  2021cites this paper
• Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment

  2021cites this paper
• Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma

  2020cites this paper
• Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma

  2020cites this paper
• Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells

  2020cites this paper
• Overcoming head and neck cancer stem cells

  2020cites this paper
• Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer

  2020influential citation
• Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy.

  2020cites this paper
• HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth

  2020cites this paper
• S100A9 promotes prostate cancer cell invasion by activating TLR4/NF-κB/integrin β1/FAK signaling

  2020cites this paper
• Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells

  2020cites this paper
• Liver cancer stem cells as a hierarchical society: yes or no?

  2020cites this paper
• Targeting cancer stem cells in cholangiocarcinoma (Review)

  2020cites this paper
• Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies

  2020cites this paper
• Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.

  2020cites this paper
• Identification, characterization and microRNA expression profiling of side population cells in human oral squamous cell carcinoma Tca8113 cell lines

  2020cites this paper
• Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling

  2020cites this paper
• Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies

  2020cites this paper
• Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells

  2019cites this paper
• A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li‐7

  2019cites this paper
• Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells

  2019cites this paper
• Digging deeper into volatile organic compounds associated with cancer

  2019cites this paper
• Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy

  2019cites this paper
• Meeting the Challenge of Targeting Cancer Stem Cells

  2019cites this paper
• Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.

  2019cites this paper
• Hypoxia and Stem Cells in Normal and Tumor Development

  2019cites this paper
• TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

  2019cites this paper
• AccessReview Stemness features in liver cancer

  2019cites this paper
• Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN

  2019cites this paper
• Unraveling the journey of cancer stem cells from origin to metastasis.

  2019cites this paper
• Hepatitis-C Virus Increases Tumorigenic Potential of Hepatocellular Carcinoma (HCC) Cells by Expanding an Aldehyde Dehydrogenase 1 (ALDH1) Positive Stem Cell Like Population

  2019cites this paper
• Antiproliferative activity of (R)-4'-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition.

  2019cites this paper
• Advances in surface markers of liver cancer stem cell

  2019cites this paper
• University of Dundee Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib Bort,

  2019cites this paper
• Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2

  2019cites this paper
• Nuclear CD44 Mediated by Importin β Participated in Naïve Genes Transcriptional Regulation in C3A-iCSCs

  2019cites this paper